# Kriya Therapeutics, Inc.: Research, Morrisville, United States

> Kriya Therapeutics, Inc.: Kriya Therapeutics, Inc. Based in Morrisville, United States. Founded 2019.

Source: https://millionrounds.com/startup/kriya-therapeutics-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Kriya Therapeutics, Inc.

Kriya Therapeutics, Inc.

Funding reported Last round: Series C

Research Morrisville, United States

Company summary

- **Founded:** 2019 7 years old
- **Team:** 200 51 to 200 people
- **Funding reported:** $601M in dollars
- **Last round:** Series C Jul 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Kriya Therapeutics, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Kriya Therapeutics, Inc.

Kriya Therapeutics, Inc.

is a biopharmaceutical gene therapy company founded in 2019, headquartered in Palo Alto, California, with additional offices in Redwood City and Research Triangle Park, North Carolina. The company focuses on designing and developing one-time gene therapies for severe chronic diseases. Kriya operates as a fully integrated platform, aiming to enhance the speed and cost-effectiveness of gene therapy development and manufacturing. Kriya specializes in adeno-associated virus (AAV)-based gene therapies, utilizing two key technology platforms: SIRVE, which enables targeted vector design, and STRIPE, a high-efficiency manufacturing platform. The company's pipeline includes investigational gene therapy candidates for metabolic diseases, ophthalmology, and neurology, addressing conditions such as type 1 and type 2 diabetes, Geographic Atrophy, and Trigeminal Neuralgia. Kriya's mission is to provide innovative therapies for patients with significant unmet medical needs in the United States and beyond.

## What company datasets say Kriya Therapeutics, Inc. raised

Funding, as reported

Reported in all **$601M** in dollars

Rounds **5**

Last round **Series C**

Last round size **$320M**

Last round date **Jul 2023**

Investors listed **16**

## Founders and team

From Kriya Therapeutics, Inc.'s own website: 7 on the team.

- **Britt Petty** Chief Man­u­fac­tur­ing Officer
- **Mark Chen** Chief Operating Officer
- **Sachiyo Minegishi** Chief Financial Officer
- **Akshay Rai** Director
- **Ilan Oren** Director
- **Jim Momtazee** Director
- **Saira Ramasastry** Director

## On 2 portfolio pages

Investors who name them

- [T1D Fund](https://millionrounds.com/fund/t1d-fund)
- [Narya](https://millionrounds.com/fund/narya)

Each firm lists Kriya Therapeutics, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

innovative treatments health care investor-backed genetic medicine thyroid eye disease product design gene therapy for eye diseases health equity transformative medicine biotech strategic partnerships biotech therapeutics biotechnology research pain management manufacturing biotech growth funding gene therapy for chronic diseases

Built with from their website

Resi Google Tag Manager Excel Impact Amazon CloudFront ServiceNow Virtual Agent WordPress.org Font Awesome Siemens PROFIBUS Intel Nios CloudFlare

+8 more

Viewport Meta Mimecast Thermo Scientific Chromeleon Chromatography Data System WP Engine Amazon S3 NetSuite CloudFlare CDN Bunny

- **Sector:** Research
- **Industry code:** NAICS 541714, 325412, SIC 2834, 2836
- **Region:** North Carolina
- **Revenue:** $28M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/kriya-therapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Kriya Therapeutics, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)